1 hr 2 min

SCOTUS Chat: The Future of Medication Abortion Access The Gender Justice Brief

    • Non-Profit

Host: Erin Maye Quade, Gender Justice Special Projects Advisor

Guests: Jess Braverman, Gender Justice Legal Director and Amanda Allen, Deputy Executive Director for Legal Programs at The Lawyering Project

Gender Justice legal and policy experts and the Lawyering Project’s Deputy Executive Director for Legal Programs Amanda Allen discuss the oral arguments in Alliance for Hippocratic Medicine v. Food and Drug Administration (FDA), the Supreme Court case challenging access to medication abortion in the U.S..

Amanda oversees The Lawyering Project’s Access & Innovation Program, which focuses on expanding access to medication abortion through telehealth and other innovative technologies and she brings her years of advocating for meaningful access to reproductive health services to the conversation. In this episode, she joins Gender Justice Legal Director Jess Braverman and Special Projects Advisor Erin Maye Quade to analyze the oral arguments in the case, review the current landscape of medication abortion access, and look ahead to what the future could bring.

Links:

Audio of the Supreme Court oral arguments in the case (transcript provided)The Lawyering Project

Gender Justice FAQ on the mifepristone lawsuits

The UnRestrict Minnesota Guide to Medication AbortionThe Current Attack on Abortion Pills Will Fail. The Next One Will Be So Much Worse. 

###

Visit the "Gender Justice" Website ⁠here⁠ and "Unrestrict Minnesota" ⁠here⁠.

The GJB is produced by Michael at ⁠www.501MediaGroup.com⁠ & Audra Grigus.


---

Send in a voice message: https://podcasters.spotify.com/pod/show/genderjustice/message

Host: Erin Maye Quade, Gender Justice Special Projects Advisor

Guests: Jess Braverman, Gender Justice Legal Director and Amanda Allen, Deputy Executive Director for Legal Programs at The Lawyering Project

Gender Justice legal and policy experts and the Lawyering Project’s Deputy Executive Director for Legal Programs Amanda Allen discuss the oral arguments in Alliance for Hippocratic Medicine v. Food and Drug Administration (FDA), the Supreme Court case challenging access to medication abortion in the U.S..

Amanda oversees The Lawyering Project’s Access & Innovation Program, which focuses on expanding access to medication abortion through telehealth and other innovative technologies and she brings her years of advocating for meaningful access to reproductive health services to the conversation. In this episode, she joins Gender Justice Legal Director Jess Braverman and Special Projects Advisor Erin Maye Quade to analyze the oral arguments in the case, review the current landscape of medication abortion access, and look ahead to what the future could bring.

Links:

Audio of the Supreme Court oral arguments in the case (transcript provided)The Lawyering Project

Gender Justice FAQ on the mifepristone lawsuits

The UnRestrict Minnesota Guide to Medication AbortionThe Current Attack on Abortion Pills Will Fail. The Next One Will Be So Much Worse. 

###

Visit the "Gender Justice" Website ⁠here⁠ and "Unrestrict Minnesota" ⁠here⁠.

The GJB is produced by Michael at ⁠www.501MediaGroup.com⁠ & Audra Grigus.


---

Send in a voice message: https://podcasters.spotify.com/pod/show/genderjustice/message

1 hr 2 min